Novartis Fortifies Immuno-Oncology Franchise with BeiGene Collaboration
In recent times, several big pharma have collaborated with small companies in the immuno-oncology field. Last September, Pfizer made a $200 million investment to collaborate with CStone Pharmaceuticals. Now Novartis …
Read More